HAEM5:Volunteer Assignments and Opportunities

WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (4th Edition) Content
Disease (5th Edition)	Page Type	Author (5th Edition)	Associate Editor	Correlated Prior Disease Name (4th Edition)	Correlated Prior Author (4th Edition)	Content Status (4th Edition)(Pending or Complete)	Date of Last Editor Review (4th Edition)	Notes (4th Edition)
CHAPTER 2 (MYELOID PROLIFERATIONS AND NEOPLASMS)
Clonal haematopoiesis	Disease		Fabiola Quintero-Rivera (FQR)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Clonal cytopenias of undetermined significance	Disease		FQR	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Chronic myeloid leukaemia	Disease		FQR	Chronic Myeloid Leukemia (CML), BCR-ABL1 Positive	Jack Reid, MD (University of California, Irvine) Mark Evans, MD (University of California, Irvine) Fabiola Quintero-Rivera, MD (University of California, Irvine)	Complete	Date page was created
Chronic neutrophilic leukaemia	Disease		FQR	Chronic Neutrophilic Leukemia (CNL)	Anamaria Munteanu, MD, Ph.D, Harbor-UCLA Medical Center, Joseph J. Merlo Jr, MD. Ph.D, Ashion Analytics, Fabiola Quintero-Rivera, University of California Irvine **contributed equally	Complete	Date page was created
Chronic eosinophilic leukaemia	Disease		FQR	Chronic Eosinophilic Leukemia, Not Otherwise Specified	Chelsea D. Kramish; Daynna J.Wolff	complete/pending faculty review
Polycythaemia vera	Disease		FQR	Polycythemia Vera (PV)	Gokce A. Toruner, MD, PhD UT MD Anderson Cancer Center	Complete
Essential thrombocythaemia	Disease		FQR	Essential Thrombocythemia (ET)	Rebecca Smith, PhD, Director, Genetics Associates, Nashville, TN	Complete
Primary myelofibrosis	Disease		FQR	Primary Myelofibrosis (PMF)	T. Niroshi Senaratne, UCLA	Complete	8/4/2020 before submission
Juvenile myelomonocytic leukaemia	Disease		FQR	Juvenile Myelomonocytic Leukemia (JMML)	Sarah Rapisardo, PhD, FACMG \| Assistant Professor, Pathology Associate Director \| Division of Molecular Pathology, Genetics and Genomics Duke University Health System Clinical Laboratories	PENDING importing content and reference formatting		FQR has emailed SR several times, last 4/20/22
Myeloproliferative neoplasm, NOS	Disease		FQR	Myeloproliferative Neoplasm (MPN), Unclassifiable	Thomas Lee, MD, PhD, University of California, Los Angeles	Complete
Cutaneous mastocytosis	Disease		FQR	Cutaneous Mastocytosis	S. Shawn Liu, MD, PhD and Thuy Phung, MD, PhD	Complete
Systemic mastocytosis	Disease		FQR	Systemic Mastocytosis	Abdullah Osme, MD, University Hospitals Cleveland Medical Center, Case Western Reserve University Shashi Shetty, Ph.D. FACMG, FCCMG, University Hospitals Cleveland Medical Center, Case Western Reserve University	Complete
Mast cell sarcoma	Disease		FQR	Mast Cell Sarcoma	Jordan Lowery, MD and Thuy Phung, MD, PhD Department of Pathology, University of South Alabama, Mobile, AL	Complete
Myelodysplastic neoplasm with low blasts and 5q deletion	Disease		FQR	Myelodysplastic Syndrome (MDS) with Isolated del(5q)	Xiaolin Hu, Ph.D; Teresa Smolarek, Ph.D, FACMG	Complete
Myelodysplastic neoplasm with low blasts and SF3B1 mutation	Disease		FQR	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Myelodysplastic neoplasm with biallelic TP53 inactivation	Disease	Eric McGinnis (assigned to new 5th edition page - FQR please follow-up to confirm)	FQR	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Myelodysplastic neoplasm with low blasts	Disease		FQR	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Myelodysplastic neoplasm, hypoplastic	Disease		FQR	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Myelodysplastic neoplasm with increased blasts	Disease		FQR	Myelodysplastic Syndrome (MDS) with Excess Blasts	Xiaoli Du, Ph.D; Teresa A. Smolarek, Ph.D, FACMG Division of Human Genetics, Cincinnati Children's Hospital Medical Center	Complete
Childhood myelodysplastic neoplasm with low blasts	Disease		FQR	Refractory Cytopenia of Childhood	Xiaoli Du, Ph.D; Teresa A. Smolarek, Ph.D, FACMG Division of Human Genetics, Cincinnati Children's Hospital Medical Center	Complete
Childhood myelodysplastic neoplasm with increased blasts	Disease		FQR	Refractory Cytopenia of Childhood	Xiaoli Du, Ph.D; Teresa A. Smolarek, Ph.D, FACMG Division of Human Genetics, Cincinnati Children's Hospital Medical Center	Complete
Chronic myelomonocytic leukaemia	Disease		FQR	Chronic Myelomonocytic Leukemia (CMML)	Linsheng Zhang, MD, PhD	Complete
Myelodysplastic/myeloproliferative neoplasm with neutrophilia	Disease		FQR	Atypical Chronic Myeloid Leukemia (aCML), BCR-ABL1 Negative	Linsheng Zhang, MD, PhD	Complete
Myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis	Disease		FQR	Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)	Anamaria Munteanu, MD, Ph.D, Harbor-UCLA Medical Center, Fabiola Quintero-Rivera, University of California Irvine	Complete	Date page was created
Myelodysplastic/myeloproliferative neoplasm, NOS	Disease		FQR	Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable	Ruth MacKinnon PhD Victorian Cancer Cytogenetics Service Melbourne, Australia	Complete
Acute promyelocytic leukaemia with PML::RARA fusion	Disease		Jennelle Hodge (JH)/ Malini Sathanoori (MS)	Acute Promyelocytic Leukemia (APL) with PML-RARA	Yiming Zhong, Ph.D., Megan Piazza, Ph.D., and Shashi Shetty, Ph.D.	Complete	03/01/2021-MS (re-review)
Acute myeloid leukaemia with RUNX1::RUNX1T1 fusion	Disease		JH_MS	Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1	Christine Bryke, MD Beth Israel Deaconess Medical Center, Boston, MA	Complete	04/26/2021-MS (re-review)
Acute myeloid leukaemia with CBFB::MYH11 fusion	Disease		JH_MS	Acute Myeloid Leukemia (AML) with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	Christine Bryke, MD Beth Israel Deaconess Medical Center, Boston, MA	Complete	03/01/2021-MS (re-review)
Acute myeloid leukaemia with DEK::NUP214 fusion	Disease		JH_MS	Acute Myeloid Leukemia (AML) with t(6;9)(p23;q34.1); DEK-NUP214	Jennelle C. Hodge, PhD, FACMG	Complete	02/24/2021-MS (re-review)
Acute myeloid leukaemia with RBM15::MRTFA fusion	Disease		JH_MS	Acute Myeloid Leukemia (AML) Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1	Jennelle C. Hodge, PhD, FACMG	Complete
Acute myeloid leukaemia with BCR::ABL1 fusion	Disease		JH_MS	Acute Myeloid Leukemia (AML) with BCR-ABL1	Kay Weng Choy MBBS, Monash Medical Centre	Complete
Acute myeloid leukaemia with KMT2A rearrangement	Disease		JH_MS	Acute Myeloid Leukemia (AML) with t(9;11)(p21.3;q23.3); KMT2A-MLLT3	Megan Piazza, Ph.D., Yiming Zhong, Ph.D., Shashi Shetty, Ph.D.	Complete	03/01/2021-MS (re-review)
Acute myeloid leukaemia with MECOM rearrangement	Disease		JH_MS	Acute Myeloid Leukemia (AML) with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM	Gordana Raca MD PhD, University of Southern California, Los Angeles	Complete		Need permission for figure? Update WHO?
Acute myeloid leukaemia with NUP98 rearrangement	Disease		JH_MS	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Acute myeloid leukaemia with NPM1 mutation	Disease		JH_MS	Acute Myeloid Leukemia (AML) with Mutated NPM1	Xinjie Xu, PhD, FACMG	Complete		Add WHO reference
Acute myeloid leukaemia with CEBPA mutation	Disease		JH_MS	Acute Myeloid Leukemia (AML) with Biallelic Mutations of CEBPA	Paul Defazio, MSc, Monash Health	Complete
Acute myeloid leukaemia, myelodysplasia-related	Disease		JH_MS	Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes	Fei Yang, MD, FACMG Oregon Health & Science University	Complete
Acute myeloid leukaemia with other defined genetic alterations	Disease		JH_MS	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)	NEW (No Prior)
Acute myeloid leukaemia with minimal differentiation	Disease		JH_MS	Acute Myeloid Leukemia (AML) with Minimal Differentiation	Celeste Eno, PhD, Cedars Sinai Medical Center, Los Angeles, Fabiola Quintero-Rivera, MD, FACMG, University of California Irvine	Complete
Acute myeloid leukaemia without maturation	Disease		JH_MS	Acute Myeloid Leukemia (AML) without Maturation	Jennelle C. Hodge, PhD, FACMG	Complete
Acute myeloid leukaemia with maturation	Disease		JH_MS	Acute Myeloid Leukemia (AML) with Maturation	Jennelle C. Hodge, PhD, FACMG	Complete
Acute basophilic leukaemia	Disease		JH_MS	Acute Basophilic Leukemia	Ashwini Yenamandra PhD FACMG	Complete
Acute myelomonocytic leukaemia	Disease		JH_MS	Acute Myelomonocytic Leukemia	Fei Yang, MD, FACMG Oregon Health & Science University	Complete
Acute monocytic leukaemia	Disease		JH_MS	Acute Monoblastic and Monocytic Leukemia	Fei Yang, MD, FACMG Oregon Health & Science University	Complete
Acute erythroid leukaemia	Disease		JH_MS	Pure Erythroid Leukemia	Ashwini Yenamandra PhD FACMG	Complete
Acute megakaryoblastic leukaemia	Disease		JH_MS	Acute Megakaryoblastic Leukemia (AMKL)	Fei Yang, MD, FACMG Oregon Health & Science University	Complete
Myeloid sarcoma	Disease		JH_MS	Myeloid Sarcoma	Yalda Naeini, MD, School of Medicine at University of California Los Angeles Fabiola Quintero-Rivera, MD, FACMG, School of Medicine at University of California Irvine	Complete
Myeloid neoplasm post cytotoxic therapy	Disease	Shawn A. Silver, DO, Shashi Shetty, Ph.D.	JH_MS
Myeloid neoplasms associated with germline predisposition	Disease		JH_MS
Myeloid proliferations associated with Down syndrome	Disease	Linda D Cooley, MD, MBA, Children's Mercy Hospital, Kansas City, MO	JH_MS
Myeloid/lymphoid neoplasm with PDGFRA rearrangement	Disease	Jay Alden, DO	FQR
Myeloid/lymphoid neoplasm with PDGFRB rearrangement	Disease	Christopher Sullivan, MD, MPH and Daynna J. Wolff, PhD	FQR
Myeloid/lymphoid neoplasm with FGFR1 rearrangement	Disease	Yanna Ding, MD PhD	FQR
Myeloid/lymphoid neoplasm with JAK2 rearrangement	Disease	Jessica Snider, M.D. and Daynna J. Wolff, PhD	FQR
Myeloid/lymphoid neoplasm with FLT3 rearrangement	Disease		FQR
Myeloid/lymphoid neoplasm with ETV6::ABL1 fusion	Disease		FQR
Myeloid/lymphoid neoplasms with other tyrosine kinase fusion genes	Disease		FQR
Mixed-phenotype acute leukaemia with BCR::ABL1 fusion	Disease	Tracy Tucker, PhD, FCCMG	JH_MS
Mixed-phenotype acute leukaemia with KMT2A rearrangement	Disease	Tracy Tucker, PhD, FCCMG	JH_MS
Acute leukaemia of ambiguous lineage with other defined genetic alterations	Disease		JH_MS
Mixed-phenotype acute leukaemia, B/myeloid	Disease	Priyatharsini Nirmalanantham, MD and Shashi Shetty, PhD	JH_MS
Mixed-phenotype acute leukaemia, T/myeloid	Disease	Narsis Attar, MD, PhD, Fabiola Quintero-Rivera, MD University of California, Irvine	JH_MS
Mixed-phenotype acute leukaemia, rare types	Disease	Elicia Goodale, MD, Medical University of South Carolina Daynna Wolff, PhD, Medical University of South Carolina	JH_MS
Acute leukaemia of ambiguous lineage, NOS	Disease		JH_MS
Acute undifferentiated leukaemia	Disease	Amelia Nakanishi, MD and Shashi Shetty, PhD	JH_MS
CHAPTER 3 (HISTIOCYTIC/DENRITIC CELL NEOPLASMS)
Mature plasmacytoid dendritic cell proliferation associated with myeloid neoplasm	Disease		Greg Corboy (GC)
Blastic plasmacytoid dendritic cell neoplasm	Disease	Hao Liu, MD and Daynna J. Wolff, PhD	GC
Langerhans cell histiocytosis	Disease	Dr Malaika Perchard BSci(MedSci), MBBS, FRACP, FRCPA, (Paediatric Haematologist) Pathology Queensland	GC
Langerhans cell sarcoma	Disease	Dr Malaika Perchard BSci(MedSci), MBBS, FRACP, FRCPA, (Paediatric Haematologist) Pathology Queensland	GC
Indeterminate dendritic cell tumour	Disease		GC
Interdigitating dendritic cell sarcoma	Disease		GC
Juvenile xanthogranuloma	Disease		GC
Erdheim-Chester disease	Disease		GC
Rosai-Dorfman Disease	Disease		GC
ALK-positive histiocytosis	Disease		GC
Histiocytic sarcoma	Disease	Marie-France Gagnon, MD, Mayo Clinic, Xinjie Xu, PhD FACMG, Mayo Clinic	GC
CHAPTER 4 (B-CELL LYMPHOID PROLIFERATIONS AND LYMPHOMAS)
Reactive B-cell rich lymphoid proliferations that can mimic lymphoma	Disease		GC
IgG4-related disease	Disease		GC
Unicentric Castleman disease	Disease		GC
Idiopathic multicentric Castleman disease	Disease		GC
KSHV/HHV8-associated multicentric Castleman disease	Disease	Sudha Arumugam, MD	GC
B-lymphoblastic leukaemia/lymphoma	Disease		Holli Drendel (HD)
B-lymphoblastic leukaemia/lymphoma with high hyperdiploidy	Disease	Afia Hasnain, MBBS, PhD; Yassmine Akkari, PhD, FACMG	HD
B-lymphoblastic leukaemia/lymphoma with hypodiploidy	Disease	Ashwini Yenamandra PhD FACMG Lisa Smith PhD FACMG Yassmine Akkari PhD FACMG	HD
B-lymphoblastic leukaemia/lymphoma with iAMP21	Disease	Holli M. Drendel, PhD, FACMGG, Carolinas Pathology Group, Charlotte	HD
B-lymphoblastic leukaemia/lymphoma with BCR::ABL1 fusion	Disease	Afia Hasnain, MBBS, PhD; Yassmine Akkari, PhD, FACMG	HD
B-lymphoblastic leukaemia/lymphoma with BCR::ABL1-like features	Disease	Mark G. Evans, MD, University of California, Irvine Fabiola Quintero-Rivera, MD, University of California, Irvine	HD
B lymphoblastic leukaemia/lymphoma with KMT2A rearrangement	Disease	Yassmine Akkari Nicolas Millan	HD
B lymphoblastic leukaemia/lymphoma with ETV6::RUNX1 fusion	Disease	Marilena Melas, PhD; Yassmine Akkari, PhD, FACMG Cancer Category/Type B-Lymphoblastic Leukemia/Lymphoma	HD
B-lymphoblastic leukaemia/lymphoma with ETV6::RUNX1-like features	Disease		HD
B lymphoblastic leukaemia/lymphoma with TCF3::PBX1 fusion	Disease	Binu Porath, PhD. Vanderbilt University Medical Center, Nashville, TN Linda D. Cooley, MD, MBA. Children's Mercy Kansas City, Kansas City, MO	HD
B lymphoblastic leukaemia/lymphoma with IGH::IL3 fusion	Disease	Binu Porath, PhD. Vanderbilt University Medical Center, Nashville, TN Linda D. Cooley, MD, MBA. Children's Mercy Kansas City, Kansas City, MO	HD
B lymphoblastic leukaemia/lymphoma with TCF3::HLF fusion	Disease		HD
B-lymphoblastic leukaemia/lymphoma with other defined genetic alterations	Disease		HD
B-lymphoblastic leukaemia/lymphoma, NOS	Disease		HD
Monoclonal B-cell lymphocytosis	Disease		Shivani Golem (SG)
Chronic lymphocytic leukaemia/small lymphocytic lymphoma	Disease	Jamie Nagy, PhD, University of Iowa Honey Reddi, PhD	SG
Hairy cell leukaemia	Disease	*Snehal Patel, MD, PhD	SG
Splenic marginal zone lymphoma	Disease	*Snehal Patel, MD, PhD	SG
Splenic diffuse red pulp small B-cell lymphoma	Disease	*Snehal Patel, MD, PhD	SG
Splenic B-cell lymphoma/leukaemia with prominent nucleoli	Disease	*Snehal Patel, MD, PhD	SG
Lymphoplasmacytic lymphoma	Disease	Kapitolina Semenova, MD, Jack Reid, MD, Fabiola Quintero-Rivera, MD Departments of Pathology, Laboratory Medicine, and *Pediatrics, Division of Genetic and Genomic Medicine, University of California, Irvine (UCI)	SG
Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue	Disease		SG
Primary cutaneous marginal zone lymphoma	Disease		SG
Nodal marginal zone lymphoma	Disease	Andrew Ly, DO and Shivani Golem, PhD, FACMG	SG
Paediatric nodal marginal zone lymphoma	Disease	* Kathleen M. Schieffer, PhD * Ruthann Pfau, PhD	SG
In situ follicular B-cell neoplasm	Disease	Rachel D. Burnside, PhD, MBA, FACMGG	SG
Follicular lymphoma	Disease	Ruthann Pfau, PhD, FACMG, Nationwide Children's Hospital Rachel D. Burnside, PhD, MBA, FACMG, University of Florida	SG
Paediatric-type follicular lymphoma	Disease	Kathleen M. Schieffer, PhD Ruthann Pfau, PhD, FACMG	SG
Duodenal-type follicular lymphoma	Disease		SG
Primary cutaneous follicle centre lymphoma	Disease	Linlin Gao, MD, PhD and Shivani Golem, PhD, FACMG	SG
In situ mantle cell neoplasm	Disease	Rina Kansal, MD; Versiti Blood Center of Wisconsin	SG
Mantle cell lymphoma	Disease	* Mahsa Khanlari, MD * Zhenya Tang, MD, PhD The University Of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas	SG
Leukaemic non-nodal mantle cell lymphoma	Disease		SG
Transformations of indolent B-cell lymphomas	Disease		SG
Diffuse large B-cell lymphoma, NOS	Disease	Ashwini Yenamandra, PhD FACMG, Vanderbilt University Medical Center	GC
T-cell/histiocyte-rich large B-cell lymphoma	Disease		GC
Diffuse large B-cell lymphoma / high grade B-cell lymphoma with MYC and BCL2 rearrangements	Disease	Kate Berry, MBBS, BBus (Hons), Pathology Queensland	GC
ALK-positive large B-cell lymphoma	Disease	Manando Nakasaki, MD, PhD (University of California, Irvine) Fabiola Quintero-Rivera, MD, FACMG (University of California, Irvine)	GC
Large B-cell lymphoma with IRF4 rearrangement	Disease	*Afia Hasnain, MBBS, PhD	GC
High grade B-cell lymphoma with 11q aberrations	Disease	Lauren Shealy, MD, Medical University of South Carolina Daynna Wolff, PhD, Medical University of South Carolina	GC
Lymphomatoid granulomatosis	Disease		GC
EBV-positive diffuse large B-cell lymphoma	Disease		GC
Diffuse large B-cell lymphoma associated with chronic inflammation	Disease		GC
Fibrin-associated large B-cell lymphoma	Disease		GC
Fluid overload-associated large B-cell lymphoma	Disease		GC
Plasmablastic lymphoma	Disease	Mark Evans, MD (University of California, Irvine) Fabiola Quintero-Rivera, MD (University of California, Irvine)	GC
Primary large B-cell lymphoma of immune-privileged sites	Disease	Ashwini Yenamandra, PhD FACMG, Vanderbilt University Medical Center	GC
Primary cutaneous diffuse large B-cell lymphoma, leg type	Disease		GC
Intravascular large B-cell lymphoma	Disease	Kate Berry, MBBS, BBus (Hons), Pathology Queensland	GC
Primary mediastinal large B-cell lymphoma	Disease		GC
Mediastinal grey zone lymphoma	Disease		GC
High-grade B-cell lymphoma, NOS	Disease	Aiko Otsubo, PhD, Indiana University	GC
Burkitt lymphoma	Disease	Becky Leung, MBBS (Hons), BSc, Pathology Queensland	GC
Primary effusion lymphoma	Disease		GC
KSHV/HHV8-positive diffuse large B-cell lymphoma	Disease		GC
KSHV/HHV8-positive germinotropic lymphoproliferative disorder	Disease		GC
Hyperplasias arising in immune deficiency/dysregulation	Disease		GC
Polymorphic lymphoproliferative disorders arising in immune deficiency / dysregulation	Disease	Anna Shestakova, MD, PhD, Fellow, University of Utah/ARUP Laboratories Fabiola Quintero-Rivera, MD, Professor, University of California Irvine (UCI)	GC
EBV-positive mucocutaneous ulcer	Disease		GC
Lymphomas arising in immune deficiency / dysregulation	Disease		GC
Inborn error of immunity-associated lymphoid proliferations and lymphomas	Disease		GC
Classic Hodgkin lymphoma	Disease	Patricia V. Hernandez, M.D., Washington University School of Medicine	GC
Nodular lymphocyte predominant Hodgkin lymphoma	Disease		GC
Cold agglutinin disease	Disease		SG
IgM monoclonal gammopathy of undetermined significance	Disease		SG
Non-IgM monoclonal gammopathy of undetermined significance	Disease		SG
Monoclonal gammopathy of renal significance	Disease		SG
Immunoglobulin-related (AL) amyloidosis	Disease	Heather E. Williams, PhD, MS, PgD, ErCLG	SG
Monoclonal immunoglobulin deposition disease	Disease	Chen Yang, MD, PhD, University of Michigan	SG
Mu heavy chain disease	Disease		SG
Gamma heavy chain disease	Disease	Manisha Brahmbhatt-Sutariya Asst. Professor, Dept. of Pathology and Human Anatomy Technical Supervisor, Clinical Genetics Laboratory Loma Linda University, Medical Center, CA	SG
Alpha heavy chain disease	Disease		SG
Plasmacytoma	Disease		SG
Plasma cell myeloma / multiple myeloma	Disease	Huan Mo, MD, MS Zhenya Tang, MD, PhD The University Of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas	SG
Plasma cell neoplasms with associated paraneoplastic syndrome	Disease	Sohini Anand, MBBS Tharanga Niroshini Senaratne, PhD	SG
CHAPTER 5 (T-CELL AND NK-CELL LYMPHOID PROLIFERATIONS AND LYMPHOMAS)
Kikuchi-Fujimoto disease	Disease		Sumi Kitahara (SK)
Autoimmune lymphoproliferative syndrome	Disease		SK
Indolent T-lymphoblastic proliferation	Disease		SK
T-lymphoblastic leukaemia / lymphoma, NOS	Disease		HD
Early T-precursor lymphoblastic leukaemia / lymphoma	Disease	Fei Yang, MD, FACMG, Kaiser Permanente Northwest	HD
T-prolymphocytic leukaemia	Disease		SK
T-large granular lymphocytic leukaemia	Disease	*Michelle Don, MD, MS	SK
NK-large granular lymphocytic leukaemia	Disease	Michelle Don, MD	SK
Adult T-cell leukaemia/lymphoma	Disease	Prasad R. Kopparapu, PhD and Ferrin C. Wheeler, PhD, FACMG Vanderbilt University Medical Center	SK
Sezary syndrome	Disease	Madison E. Hannay, DO, Medical University of South Carolina Tingting Barrett, MD, Medical University of South Carolina Daynna J. Wolff, PhD, Medical University of South Carolina	SK
Aggressive NK-cell leukaemia	Disease	Shanelle De Lancy, MD, Shashirekha Shetty, PhD	SK
Primary cutaneous CD4-positive small or medium T-cell lymphoproliferative disorder	Disease		SK
Primary cutaneous acral CD8-positive T-cell lymphoproliferative disorder	Disease		SK
Mycosis fungoides	Disease	Jane Scribner, MD and Daynna J. Wolff, PhD	SK
Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Lymphomatoid papulosis	Disease		SK
Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Primary cutaneous anaplastic large cell lymphoma	Disease	Theresa Spivey, MD, Shashirekha Shetty, PhD	SK
Subcutaneous panniculitis-like T-cell lymphoma	Disease		SK
Primary cutaneous gamma/delta T-cell lymphoma	Disease		SK
Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma	Disease		SK
Primary cutaneous peripheral T-cell lymphoma, NOS	Disease		SK
Indolent T-cell lymphoma of the gastrointestinal tract	Disease	Derick Okwan-Duodu MD, PhD; Sumire Kitahara, MD	SK
Indolent NK-cell lymphoproliferative disorder of the gastrointestinal tract	Disease		SK
Enteropathy-associated T-cell lymphoma	Disease	Derick Okwan-Duodu, MD, PhD Sumire Kitahara, MD	SK
Monomorphic epitheliotropic intestinal T-cell lymphoma	Disease	Derick Okwan-Duodu MD, PhD; Sumire Kitahara, MD	SK
Intestinal T-cell lymphoma, NOS	Disease	Derick Okwan MD, PhD (Stanford Medicine, CA) Sumire Kitahara MD (Cedars-Sinai, CA)	SK
Hepatosplenic T-cell lymphoma	Disease	*Michelle Don, MD, MS	SK
ALK-positive anaplastic large cell lymphoma	Disease		SK
ALK-negative anaplastic large cell lymphoma	Disease	Miguel Gonzalez Mancera, MD Sumire Kitahara, MD Cedars-Sinai, Los Angeles, CA	SK
Breast implant-associated anaplastic large cell lymphoma	Disease	Derick Okwan-Duodu, MD, PhD; Sumire Kitahara, MD Cedars-Sinai Medical Center	SK
Nodal TFH cell lymphoma, angioimmunoblastic-type	Disease	* Sara Akhavanfard, M.D., Ph.D. * Ruthann Pfau, Ph.D., FACMG	SK
Nodal TFH cell lymphoma, follicular-type	Disease		SK
Nodal TFH cell lymphoma, NOS	Disease	Hans Magne Hamnvåg, MD Kamran Mirza, MD, PhD	SK
Peripheral T-cell lymphoma, NOS	Disease		SK
EBV-positive nodal T- and NK-cell lymphoma	Disease		SK
Extranodal NK/T-cell lymphoma	Disease		SK
Severe mosquito bite allergy	Disease		SK
Hydroa vacciniforme lymphoproliferative disorder	Disease		SK
Systemic chronic active EBV disease	Disease		SK
Systemic EBV-positive T-cell lymphoma of childhood	Disease	*Lisa A. Lansdon, PhD & Linda D. Cooley, MD, MBA	SK
CHAPTER 6 (STROMA-DERIVED NEOPLASMS OF LYMPHOID TISSUES)
Follicular dendritic cell sarcoma	Disease	Anna Heimes Dillon, MD and Shivani Golem, PhD, FACMG	GC
EBV-positive inflammatory follicular dendritic cell sarcoma	Disease		GC
Fibroblastic reticular cell tumour	Disease		GC
Intranodal palisaded myofibroblastoma	Disease		GC
Littoral cell angioma	Disease		GC
Splenic hamartoma	Disease		GC
Sclerosing angiomatoid nodular transformation (SANT) of spleen	Disease		GC
CHAPTER 7 (GENETIC TUMOUR SYNDROMES)
Fanconi anaemia	Disease		NA
Bloom syndrome	Disease		NA
Ataxia-telangiectasia syndrome	Disease		NA
RASopathies	Disease		NA